Kingdon Capital Management, L.L.C. Jasper Therapeutics, Inc. Transaction History

Kingdon Capital Management, L.L.C.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$0.42 - $0.93 $210,000 - $465,000	500,000 Added 16.45%	3,540,000 $2.8 Million
Q1 2023 May 15, 2023	BUY	$1.48 - $2.74 $3.7 Million - $6.85 Million	2,500,000 Added 462.96%	3,040,000 $5.5 Million
Q4 2021 Feb 14, 2022	BUY	$7.21 - $16.42 $3.89 Million - $8.87 Million	540,000 New	540,000 $4.24 Million

5.63M

Ticker JSPR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,073,300
Market Cap $962M
Description
Jasper Therapeutics, Inc., a clinical-stage biotechnology company, develops therapeutic agents for hematopoietic stem cell transplantation and gene therapies. It focuses on the development and commercialization of conditioning agents and stem cell engineering to allow expanded use of stem cell transplantation and ex vivo gene therapy, a techniqu...

Get notified when there are updates to the investment portfolio of Kingdon Capital Management, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Kingdon Capital Management, L.L.C. with notifications on news.